1 comment

[ 2.5 ms ] story [ 14.8 ms ] thread
As of March 9, “22 cases of thromboembolic events had been reported among the 3 million people vaccinated with COVID-19 Vaccine AstraZeneca in the European Economic Area,” the EMA said.